FDA Issues Warning About Rare but Serious Liver Injury With the Use of Fezolinetant (VEOZAH) for Hot Flashes Due to Menopause
View all alerts
Worst Pills, Best Pills

An expert, independent second opinion on more than 1,800 prescription drugs, over-the-counter medications, and supplements

phenylpropanolamine (DEXATRIM)


DRUG AND DIETARY SUPPLEMENT PROFILES

A comprehensive review of the safety and effectiveness of this drug. If the drug is not a Do Not Use product, information on adverse effects, drug interactions and how to use the medication are included.
Search results below include Drug and Dietary Supplement Profiles where your selected drug is a secondary subject of discussion.

ephedra [ma huang, chinese ephedra, epitonin]
  • We list this drug as a Do Not Use drug because there is no evidence that it is effective and it causes heart attacks, strokes and seizures.
pseudoephedrine (ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION, SUDAFED, SUDAFED 12 HOUR, SUDOGEST)
  • We list this drug as a Do Not Use drug because it raises heart rate and blood pressure and causes heart attacks and strokes.

WORST PILLS, BEST PILLS NEWSLETTER ARTICLES

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a secondary subject of discussion.

When EMA and FDA Decisions Conflict: Differences in Patients or in Regulation?
December 2013
Are Americans more resistant to the risks and more likely to benefit from certain drugs than Europeans? Or is the European Medicines Agency (EMA) more resistant than the U.S. Food and Drug Administration (FDA) to the drug industry’s desire to get approval for drugs with unique risks but without compensating benefits? This article discusses two recently FDA-approved diet drugs deemed too unsafe for Europeans.

ADDITIONAL INFORMATION FROM PUBLIC CITIZEN

Search results below include Additional Information from Public Citizen where your selected drug is a secondary subject of discussion.

Statement Before the Institute of Medicine Committee Assessing the U.S. Drug Safety System (HRG Publication #1759)
Testimony on the adequacy and conclusions of FDA’s pre-approval review and ongoing post-approval reviews.

Show primary search results for phenylpropanolamine (DEXATRIM)

Disclaimer

The information on this website is not intended to substitute for professional medical advice, diagnosis, or treatment. Consult your doctor before changing or discontinuing any medication.